1. Cohen MS, Shaw GM, McMichael AJ, et al. Acute HIV-1 Infection. N Engl J Med. 364: 1943-54, 2011.
  2. DHHS: Guideline for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV (Feb 24, 2021). https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv/whats-new-guidelines
  3. Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral Drugs for treatment and Prevention of HIV infection in Adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 324: 1651-1669, 2020.
  4. BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update)(https://www.bhiva.org/HIV-1-treatment-guidelines).
  5. European AIDS clinical society (EACS) guideline (Version 10.1, Octomber 2020) (https://www.eacsociety.org/guidelines/eacsguidelines/eacs-guidelines.html)
  6. Principles and practice of Infectious Disease. Mandell, Douglas, and Bennett’s 9th edition, 1659-60, 2019.
  7. Chu C and Selwyn PA. Diagnosis and initial management of acute HIV infection. Am Fam Physician. 81: 1239-44, 2010.
  8. 診療におけるHIV-1/2感染症診断ガイドライン2020版, 日本エイズ学会・日本臨床検査医学会 標準推奨法 (https://jaids.jp/wpsystem/wp-content/uploads/2020/10/guidelines.pdf)
  9. Kondo M, Sudo K, Sano T, et al. Comparative evaluation of the Geenius HIV 1/2 Confirmatory Assay and the HIV-1 and HIV-2 Western blots in the Japanese population. PLoS ONE 13: e0198924, 2018.
  10. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-70, 1996.
  11. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 373: 795-807, 2015.
  12. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, et al. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. N Engl J Med. 373: 808-22, 2015.
  13. Cohen MS, Chen YQ, McCauley M, et al.; HPTN 052 Study Team. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 375: 830-9, 2016.
  14. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 393: 2428-2438, 2019.
  15. 菊地 正、蜂谷敦子、西澤雅子ら. 国内新規HIV/AIDS診断症例における薬剤耐性HIV-1の動向. 日本エイズ学会誌. 22: 440, 2020.
  16. HIV薬剤耐性検査ガイドライン ver, 10(平成28年度 日本医療研究開発機構 エイズ対策実用化研究事業「国内流行HIV及びその薬剤耐性株の長期的動向把握に関する研究」班)(https://www.hiv-resistance.jp/resistance04.htm)
  17. Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med. 379: 979-81, 2018.
  18. Zash R, Holmes L, Diseko M, et al. Neural-tube defects and antiretroviral treatment regimens in Botswana. N Engl J Med. 381: 827-40, 2019.
  19. Zash R, Holmes L, Diseko M, et al. Update on neural tube defects with antiretroviral exposure in the Tsepamo study, Botswana. 23rd International AIDS Conference 2020. #OAXLB0102.
  20. Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. (米国DHHS、Feb. 10, 2021). https://clinicalinfo.hiv.gov/en/guidelines/perinatal/whats-new-guidelines
  21. Lisziewicz J, Rosenberg E, Lieberman J, et al. Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med. 340: 1683-4, 1999.
  22. Lori F. and Lisziewick J. Structured Treatment Interruption for the Management of HIV Infection. JAMA 286: 2981-7, 2001.
  23. Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis. 194: 725-33, 2006.
  24. SPARTAC Trial Investigators, Fidler S, Porter K, Ewings F, et al. Short-course antiretroviral therapy in primary HIV infection. N Engl J Med. 368: 207-17, 2013.
  25. Stöhr W, Fidler S, McClure M, et al. Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy. PLoS One. 8: e78287, 2013.